Sign Up to like & get
recommendations!
0
Published in 2018 at "Molecular Oncology"
DOI: 10.1002/1878-0261.12331
Abstract: Recently, we have developed a diphtheria toxin‐based recombinant anti‐human CCR4 immunotoxin for targeting CCR4+ tumors and Tregs. In this study, we further optimized the dosing schedule for improved CCR4+ Treg depletion. We have demonstrated that…
read more here.
Keywords:
depletion;
ccr4;
ccr4 immunotoxin;
ccr4 treg ... See more keywords